哺乳动物Hippo信号通路分子机制研究进展

doi:10.16288/j.yczz.17-094

遗传 ›› 2017, Vol. 39 ›› Issue (7): 546-567.doi: 10.16288/j.yczz.17-094

哺乳动物Hippo信号通路分子机制研究进展

吉新彦¹(),钟国轩¹,赵斌^1,²()

1. 浙江大学生命科学研究院,细胞信号网络协同创新中心,杭州 310058
2. 杭州师范大学衰老研究所,杭州 311121

收稿日期:2017-03-18 修回日期:2017-04-23 出版日期:2017-07-20 发布日期:2017-05-08
作者简介:吉新彦,博士研究生,专业方向：细胞生物学。E-mail: jixinyan@zju.edu.cn|赵斌,教授,博士生导师,研究方向：Hippo信号转导通路。E-mail: binzhao@zju.edu.cn
基金资助:
国家自然科学基金项目(31422036, 31471316, 31661130150);国家重大科学研究计划项目子课题(2013CB945303);中央高校基本科研业务费专项资金(2015XZZX004-17);国家千人计划青年项目和杭州钱江学者计划项目

Molecular mechanisms of the mammalian Hippo signaling pathway

Ji Xinyan¹(),Zhong Guoxuan¹,Zhao Bin^1,²(),

1. Life Sciences Institute and the Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou 310058, China
2. Institute of Aging Research, Hangzhou Normal University, Hangzhou 311121, China

Received:2017-03-18 Revised:2017-04-23 Online:2017-07-20 Published:2017-05-08
Supported by:
the National Natural Science Foundation of China(31422036, 31471316, 31661130150);the State Key Development Program for Basic Research of China(2013CB945303);the Fundamental Research Funds for Central Universities of China(2015XZZX004-17);the Thousand Young Talents Plan of China and the Qianjiang Scholar Plan of Hangzhou

摘要/Abstract

摘要：

Hippo信号通路是近年来发现的在多细胞生物器官大小调控方面发挥重要作用的信号通路。病人样品分析和小鼠模型研究表明,Hippo信号通路的失调在多种癌症发生发展的不同阶段起着关键作用。Hippo信号通路能感知机械环境、G蛋白耦联受体信号和细胞能量水平等多种外界刺激,并通过蛋白激酶链的激活直接磷酸化转录辅激活因子YAP(Yes-associated protein)及其同源蛋白TAZ(transcriptional coactivator with PDZ-binding motif),从而导致它们的胞质滞留和降解。非磷酸化形式的YAP/TAZ进入细胞核内通过结合TEAD家族及其他转录因子激活靶基因的转录表达,从而促进细胞增殖、促进干细胞及祖细胞的自我更新、抑制细胞凋亡。在这些细胞生物学过程的协同作用下,Hippo信号通路调控器官大小、组织再生及肿瘤的发生发展。本文概述了哺乳动物Hippo信号通路的分子机制,重点介绍了Hippo信号通路的激酶链及其上游信号、Hippo信号通路调控其关键效应分子YAP的机制以及YAP调控基因转录发挥功能的分子机制。

关键词: Hippo信号通路, YAP, 器官大小, 肿瘤, 磷酸化

Abstract:

The Hippo pathway plays an evolutionarily conserved fundamental role in controlling organ size in multicellular organisms. Importantly, evidence from studies of patient samples and mouse models clearly indicates that deregulation of the Hippo signaling pathway plays a crucial role in the initiation and progression of many different types of human cancers. The Hippo signaling pathway is regulated by various stimuli, such as mechanical stress, G-protein coupled receptor signaling, and cellular energy status. When activated, the Hippo kinase cascade phosphorylates and inhibits the transcription co-activator YAP (Yes-associated protein), and its paralog TAZ (transcriptional coactivator with PDZ-binding motif), resulting in their cytoplasmic retention and degradation. When the Hippo signaling pathway is inactive, dephosphorylated YAP/TAZ translocate into the nucleus and activate gene transcription through binding to TEAD (TEA domain) family and other transcription factors. Such changes in gene expression promote cell proliferation and stem cell/progenitor cell self-renewal but inhibit apoptosis, thereby coordinately promote increase in organ size, tissue regeneration, and tumorigenesis. In this review, we summarize the molecular mechanisms of the mammalian Hippo signaling pathway with special emphasis on the Hippo kinase cascade and its upstream signals, the Hippo signaling pathway regulation of YAP and the mechanisms of YAP in regulation of gene transcription.

Key words: Hippo signaling pathway, YAP, organ size, tumor, phosphorylation

吉新彦, 钟国轩, 赵斌. 哺乳动物Hippo信号通路分子机制研究进展[J]. 遗传, 2017, 39(7): 546-567.

Ji Xinyan, Zhong Guoxuan, Zhao Bin. Molecular mechanisms of the mammalian Hippo signaling pathway[J]. Hereditas(Beijing), 2017, 39(7): 546-567.

参考文献

[1]	Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev, 1995, 9(5): 534-546.
[2]	Xu T, Wang W, Zhang S, Stewart RA, Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development, 1995, 121(4): 1053-1063.
[3]	Tapon N, Harvey KF, Bell DW, Wahrer DC, Schiripo TA, Haber D, Hariharan IK. Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell, 2002, 110(4): 467-478.
[4]	Kango-Singh M, Nolo R, Tao C, Verstreken P, Hiesinger PR, Bellen HJ, Halder G. Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development, 2002, 129(24): 5719-5730.
[5]	Pantalacci S, Tapon N, Leopold P. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat Cell Biol, 2003, 5(10): 921-927.
[6]	Udan RS, Kango-Singh M, Nolo R, Tao CY, Halder G. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol, 2003, 5(10): 914-920.
[7]	Harvey KF, Pfleger CM, Hariharan IK. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell, 2003, 114(4): 457-467.
[8]	Wu SA, Huang JB, Dong JX, Pan DJ. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell, 2003, 114(4): 445-456.
[9]	Jia J, Zhang W, Wang B, Trinko R, Jiang J. The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev, 2003, 17(20): 2514-2519.
[10]	Lai ZC, Wei X, Shimizu T, Ramos E, Rohrbaugh M, Nikolaidis N, Ho LL, Li Y. Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell, 2005, 120(5): 675-685.
[11]	Edgar BA. From cell structure to transcription: hippo forges a new path. Cell, 2006, 124(2): 267-273.
[12]	Huang JB, Wu SA, Barrera J, Matthews K, Pan DJ. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell, 2005, 122(3): 421-434.
[13]	Yagi R, Chen LF, Shigesada K, Murakami Y, Ito Y. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J, 1999, 18(9): 2551-2562.
[14]	Strano S, Munarriz E, Rossi M, Castagnoli L, Shaul Y, Sacchi A, Oren M, Sudol M, Cesareni G, Blandino G. Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J Biol Chem, 2001, 276(18): 15164-15173.
[15]	Vassilev A, Kaneko KJ, Shu HJ, Zhao YM, DePamphilis ML. TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev, 2001, 15(10): 1229-1241.
[16]	Zhao B, Ye X, Yu JD, Li L, Li WQ, Li SM, Yu JJ, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, Guan KL. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev, 2008, 22(14): 1962-1971.
[17]	Goulev Y, Fauny JD, Gonzalez-Marti B, Flagiello D, Silber J, Zider A. SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila. Curr Biol, 2008, 18(6): 435-441.
[18]	Wu SA, Liu Y, Zheng YG, Dong JX, Pan DJ. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell, 2008, 14(3): 388-398.
[19]	Zhang L, Ren FF, Zhang Q, Chen YB, Wang B, Jiang J. The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev Cell, 2008, 14(3): 377-387.
[20]	Tao WF, Zhang S, Turenchalk GS, Stewart RA, St JM, Chen W, Xu T. Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity. Nat Genet, 1999, 21(2): 177-181.
[21]	Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L, Chen Y, Park O, Chang J, Simpson RM, Wang CY, Gao B, Jiang J, Yang Y. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA, 2010, 107(4): 1431-1436.
[22]	Zhou DW, Conrad C, Xia F, Park JS, Payer B, Yin Y, Lauwers GY, Thasler W, Lee JT, Avruch J, Bardeesy N. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell, 2009, 16(5): 425-438.
[23]	Dong JX, Feldmann G, Huang JB, Wu SA, Zhang NL, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan DJ. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell, 2007, 130(6): 1120-1133.
[24]	Camargo FD, Gokhale S, Johnnidis JB, Fu DD, Bell GW, Jaenisch R, Brummelkamp TR. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol, 2007, 17(23): 2054-2060.
[25]	Graves JD, Gotoh Y, Draves KE, Ambrose D, Han DKM, Wright M, Chernoff J, Clark EA, Krebs EG. Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J, 1998, 17(8): 2224-2234.
[26]	Callus BA, Verhagen AM, Vaux DL. Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J, 2006, 273(18): 4264-4276.
[27]	Lee JH, Kim TS, Yang TH, Koo BK, Oh SP, Lee KP, Oh HJ, Lee SH, Kong YY, Kim JM, Lim DS. A crucial role of WW45 in developing epithelial tissues in the mouse. EMBO J, 2008, 27(8): 1231-1242.
[28]	Praskova M, Khoklatchev A, Ortiz-Vega S, Avruch J. Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochem J, 2004, 381(Pt 2): 453-462.
[29]	Densham RM, O'Neill E, Munro J, K?nig I, Anderson K, Kolch W, Olson MF. MST kinases monitor actin cytoskeletal integrity and signal via c-Jun N-terminal kinase stress-activated kinase to regulate p21 Waf1/Cip1 stability. Mol Cell Biol, 2009, 29(24): 6380-6390.
[30]	Poon CLC, Lin JI, Zhang XM, Harvey KF. The sterile 20-like kinase Tao-1 controls tissue growth by regulating the Salvador-Warts-Hippo pathway. Dev Cell, 2011, 21(5): 896-906.
[31]	Boggiano JC, Vanderzalm PJ, Fehon RG. Tao-1 phosphorylates Hippo/MST kinases to regulate the Hippo-Salvador-Warts tumor suppressor pathway. Dev Cell, 2011, 21(5): 888-895.
[32]	Plouffe SW, Meng ZP, Lin KC, Lin B, Hong AW, Chun JV, Guan KL. Characterization of hippo pathway components by gene inactivation. Mol Cell, 2016, 64(5): 993-1008.
[33]	Chan EHY, Nousiainen M, Chalamalasetty RB, Sch?fer A, Nigg EA, Silljé HH. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene, 2005, 24(12): 2076-2086.
[34]	Praskova M, Xia F, Avruch J. MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr Biol, 2008, 18(5): 311-321.
[35]	Ni LS, Zheng YG, Hara M, Pan DJ, Luo XL. Structural basis for Mob1-dependent activation of the core Mst-Lats kinase cascade in Hippo signaling. Genes Dev, 2015, 29(13): 1416-1431.
[36]	Li Q, Li SX, Mana-Capelli S, Flach RJR, Danai LV, Amcheslavsky A, Nie YC, Kaneko S, Yao XH, Chen XC, Cotton JL, Mao JH, McCollum D, Jiang J, Czech MP, Xu L, Ip YT. The conserved misshapen-warts-Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in Drosophila. Dev Cell, 2014, 31(3): 291-304.
[37]	Meng Z, Moroishi T, Mottier-Pavie V, Plouffe SW, Hansen CG, Hong AW, Park HW, Mo JS, Lu W, Lu S, Flores F, Yu FX, Halder G, Guan KL. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway. Nat Commun, 2015, 6: 8357.
[38]	Zheng YG, Wang W, Liu B, Deng H, Uster E, Pan DJ. Identification of happyhour/MAP4K as alternative Hpo/Mst-like kinases in the hippo kinase cascade. Dev Cell, 2015, 34(6): 642-655.
[39]	Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, Zhao JG, Yuan HX, Tumaneng K, Li HR, Fu XD, Mills GB, Guan KL. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell, 2012, 150(4): 780-791.
[40]	Zhao B, Wei XM, Li WQ, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu JD, Li L, Zheng P, Ye KQ, Chinnaiyan A, Halder G, Lai ZC, Guan KL. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev, 2007, 21(21): 2747-2761.
[41]	Miller E, Yang JY, DeRan M, Wu CL, Su AI, Bonamy GMC, Liu J, Peters EC, Wu X. Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. Chem Biol, 2012, 19(8): 955-962.
[42]	Cai H, Xu Y. The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells. Cell Commun Signal, 2013, 11: 31.
[43]	Mo JS, Yu FX, Gong R, Brown JH, Guan KL. Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs). Genes Dev, 2012, 26(19): 2138-2143.
[44]	Sorrentino G, Ruggeri N, Specchia V, Cordenonsi M, Mano M, Dupont S, Manfrin A, Ingallina E, Sommaggio R, Piazza S, Rosato A, Piccolo S, Del SG. Metabolic control of YAP and TAZ by the mevalonate pathway. Nat Cell Biol, 2014, 16(4): 357-366.
[45]	Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat Rev Cancer, 2007, 7(2): 79-94.
[46]	Zhao B, Li L, Wang L, Wang CY, Yu JD, Guan KL. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev, 2012, 26(1): 54-68.
[47]	Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell, 2006, 126(4): 677-689.
[48]	Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S, Elvassore N, Piccolo S. Role of YAP/TAZ in mechanotransduction. Nature, 2011, 474(7350): 179-183.
[49]	Yin F, Yu JZ, Zheng YG, Chen Q, Zhang NL, Pan DJ. Spatial organization of hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell, 2013, 154(6): 1342-1355.
[50]	Rauskolb C, Sun SG, Sun GP, Pan YW, Irvine KD. Cytoskeletal tension inhibits Hippo signaling through an Ajuba-Warts complex. Cell, 2014, 158(1): 143-156.
[51]	Codelia VA, Sun GP, Irvine KD. Regulation of YAP by mechanical strain through Jnk and Hippo signaling. Curr Biol, 2014, 24(17): 2012-2017.
[52]	Mo JS, Meng ZP, Kim YC, Park HW, Hansen CG, Kim S, Lim DS, Guan KL. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat Cell Biol, 2015, 17(4): 500-510.
[53]	Wang WQ, Xiao ZD, Li X, Aziz KE, Gan B, Johnson RL, Chen JJ. AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nat Cell Biol, 2015, 17(4): 490-499.
[54]	Song QH, Mao BB, Cheng JB, Gao YH, Jiang K, Chen J, Yuan ZQ, Meng SS. YAP enhances autophagic flux to promote breast cancer cell survival in response to nutrient deprivation. PLoS One, 2015, 10(3): e120790.
[55]	DeRan M, Yang JY, Shen CH, Peters EC, Fitamant J, Chan P, Hsieh M, Zhu SY, Asara JM, Zheng B, Bardeesy N, Liu J, Wu X. Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein. Cell Rep, 2014, 9(2): 495-503.
[56]	Mao BB, Gao YH, Bai YJ, Yuan ZQ. Hippo signaling in stress response and homeostasis maintenance. Acta Biochim Biophys Sin (Shanghai), 2015, 47(1): 2-9.
[57]	Lehtinen MK, Yuan ZQ, Boag PR, Yang Y, Villén J, Becker EBE, DiBacco S, de la Iglesia N, Gygi S, Blackwell TK, Bonni A. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell, 2006, 125(5): 987-1001.
[58]	Liu WZ, Wu JB, Xiao L, Bai YJ, Qu AQ, Zheng Z, Yuan ZQ. Regulation of neuronal cell death by c-Abl-Hippo/MST2 signaling pathway. PLoS One, 2012, 7(5): e36562.
[59]	Xiao L, Chen DM, Hu P, Wu JB, Liu WZ, Zhao YH, Cao M, Fang Y, Bi WZ, Zheng Z, Ren J, Ji GJ, Wang Y, Yuan ZQ. The c-Abl-MST1 signaling pathway mediates oxidative stress-induced neuronal cell death. J Neurosci, 2011, 31(26): 9611-9619.
[60]	Yuan ZQ, Kim D, Shu SK, Wu JB, Guo JP, Xiao L, Kaneko S, Coppola D, Cheng JQ. Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120. J Biol Chem, 2010, 285(6): 3815-3824.
[61]	Del Re DP, Yang YF, Nakano N, Cho J, Zhai PY, Yamamoto T, Zhang NL, Yabuta N, Nojima H, Pan DJ, Sadoshima J. Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury. J Biol Chem, 2013, 288(6): 3977-3988.
[62]	Shao D, Zhai PY, Del Re DP, Sciarretta S, Yabuta N, Nojima H, Lim DS, Pan DJ, Sadoshima J. A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat Commun, 2014, 5: 3315.
[63]	Ma B, Chen Y, Chen L, Cheng HC, Mu CL, Li J, Gao RZ, Zhou CQ, Cao L, Liu JH, Zhu YS, Chen Q, Wu SA. Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. Nat Cell Biol, 2015, 17(1): 95-103.
[64]	Xiang LS, Gilkes DM, Hu HX, Takano N, Luo WB, Lu HQ, Bullen JW, Samanta D, Liang HJ, Semenza GL. Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype. Oncotarget, 2014, 5(24): 12509-12527.
[65]	Sudol M. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene, 1994, 9(8): 2145-2152.
[66]	Sudol M, Bork P, Einbond A, Kastury K, Druck T, Negrini M, Huebner K, Lehman D. Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel protein module, the WW domain. J Biol Chem, 1995, 270(24): 14733-14741.
[67]	Sudol M, Chen HI, Bougeret C, Einbond A, Bork P. Characterization of a novel protein-binding module-the WW domain. FEBS Lett, 1995, 369(1): 67-71.
[68]	Chen HI, Sudol M. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc Natl Acad Sci USA, 1995, 92(17): 7819-7823.
[69]	Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, Donowitz M, Hisaminato A, Fujiwara T, Ito Y, Cantley LC, Yaffe MB. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J, 2000, 19(24): 6778-6791.
[70]	Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH, Zhao SM, Xiong Y, Guan KL. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol, 2008, 28(7): 2426-2436.
[71]	Morin-Kensicki EM, Boone BN, Howell M, Stonebraker JR, Teed J, Alb JG, Magnuson TR, O'Neal W, Milgram SL. Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65. Mol Cell Biol, 2006, 26(1): 77-87.
[72]	Makita R, Uchijima Y, Nishiyama K, Amano T, Chen Q, Takeuchi T, Mitani A, Nagase T, Yatomi Y, Aburatani H, Nakagawa O, Small EV, Cobo-Stark P, Igarashi P, Murakami M, Tominaga J, Sato T, Asano T, Kurihara Y, Kurihara H. Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ. Am J Physiol Renal Physiol, 2008, 294(3): F542-F553.
[73]	Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP. Genes Dev, 2010, 24(1): 72-85.
[74]	Wang JY, Park JS, Wei YY, Rajurkar M, Cotton JL, Fan QS, Lewis BC, Ji HK, Mao JH. TRIB2 acts downstream of Wnt/TCF in liver cancer cells to regulate YAP and C/EBPα function. Mol Cell, 2013, 51(2): 211-225.
[75]	Kim M, Kim M, Lee S, Kuninaka S, Saya H, Lee H, Lee S, Lim DS. cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes. EMBO J, 2013, 32(11): 1543-1555.
[76]	Yu FX, Zhang YF, Park HW, Jewell JL, Chen Q, Deng YT, Pan DJ, Taylor SS, Lai ZC, Guan KL. Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation. Genes Dev, 2013, 27(11): 1223-1232.
[77]	Rosenbluh J, Nijhawan D, Cox AG, Li XN, Neal JT, Schafer EJ, Zack TI, Wang XX, Tsherniak A, Schinzel AC, Shao DD, Schumacher SE, Weir BA, Vazquez F, Cowley GS, Root DE, Mesirov JP, Beroukhim R, Kuo CJ, Goessling W, Hahn WC. β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell, 2012, 151(7): 1457-1473.
[78]	Zaidi SK, Sullivan AJ, Medina R, Ito Y, van Wijnen AJ, Stein JL, Lian JB, Stein GS. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J, 2004, 23(4): 790-799.
[79]	Calvo F, Ege N, Grande-Garcia A, Hooper S, Jenkins RP, Chaudhry SI, Harrington K, Williamson P, Moeendarbary E, Charras G, Sahai E. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol, 2013, 15(6): 637-646.
[80]	Levy D, Adamovich Y, Reuven N, Shaul Y. Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell, 2008, 29(3): 350-361.
[81]	Yang SP, Zhang L, Liu M, Chong R, Ding SJ, Chen YH, Dong JX. CDK1 phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation. Cancer Res, 2013, 73(22): 6722-6733.
[82]	Oudhoff MJ, Freeman SA, Couzens AL, Antignano F, Kuznetsova E, Min PH, Northrop JP, Lehnertz B, Barsyte-Lovejoy D, Vedadi M, Arrowsmith CH, Nishina H, Gold MR, Rossi FMV, Gingras AC, Zaph C. Control of the hippo pathway by Set7-dependent methylation of Yap. Dev Cell, 2013, 26(2): 188-194.
[83]	Hata S, Hirayama J, Kajiho H, Nakagawa K, Hata Y, Katada T, Furutani-Seiki M, Nishina H. A novel acetylation cycle of transcription co-activator Yes-associated protein that is downstream of Hippo pathway is triggered in response to SN2 alkylating agents. J Biol Chem, 2012, 287(26): 22089-22098.
[84]	Wang WQ, Huang J, Chen JJ. Angiomotin-like proteins associate with and negatively regulate YAP1. J Biol Chem, 2011, 286(6): 4364-4370.
[85]	Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei QY, Guan KL. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev, 2011, 25(1): 51-63.
[86]	Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang CX, Hong WJ. Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem, 2011, 286(9): 7018-7026.
[87]	Liu X, Yang N, Figel SA, Wilson KE, Morrison CD, Gelman IH, Zhang J. PTPN14 interacts with and negatively regulates the oncogenic function of YAP. Oncogene, 2013, 32(10): 1266-1273.
[88]	Wang WQ, Huang J, Wang X, Yuan JS, Li X, Feng L, Park JI, Chen JJ. PTPN14 is required for the density-dependent control of YAP1. Genes Dev, 2012, 26(17): 1959-1971.
[89]	Silvis MR, Kreger BT, Lien WH, Klezovitch O, Rudakova GM, Camargo FD, Lantz DM, Seykora JT, Vasioukhin V. α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci Signal Genes Dev, 2011, 4(174): ra33.
[90]	Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou DW, Kreger BT, Vasioukhin V, Avruch J, Brummelkamp TR, Camargo FD. Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell, 2011, 144(5): 782-795.
[91]	Oka T, Remue E, Meerschaert K, Vanloo B, Boucherie C, Gfeller D, Bader GD, Sidhu SS, Vandekerckhove J, Gettemans J, Sudol M. Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling. Biochem J, 2010, 432(3): 461-472.
[92]	Remue E, Meerschaert K, Oka T, Boucherie C, Vandekerckhove J, Sudol M, Gettemans J. TAZ interacts with zonula occludens-1 and-2 proteins in a PDZ-1 dependent manner. FEBS Lett, 2010, 584(19): 4175-4180.
[93]	Komuro A, Nagai M, Navin NE, Sudol M. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem, 2003, 278(35): 33334-33341.
[94]	Wu HT, Xiao YB, Zhang SH, Ji SY, Wei LY, Fan FQ, Geng J, Tian J, Sun XF, Qin FN, Jin CN, Lin JJ, Yin ZY, Zhang T, Luo LZ, Li Y, Song SY, Lin SC, Deng XM, Camargo F, Avruch J, Chen LF, Zhou DW. The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense. Cell Rep, 2013, 3(5): 1663-1677.
[95]	Danovi SA, Rossi M, Gudmundsdottir K, Yuan M, Melino G, Basu S. Yes-associated protein (YAP) is a critical mediator of c-Jun-dependent apoptosis. Cell Death Differ, 2008, 15(1): 217-219.
[96]	Liu AM, Poon RT, Luk JM. MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun, 2010, 394(3): 623-627.
[97]	Nishikawa E, Osada H, Okazaki Y, Arima C, Tomida S, Tatematsu Y, Taguchi A, Shimada Y, Yanagisawa K, Yatabe Y, Toyokuni S, Sekido Y, Takahashi T. miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res, 2011, 71(19): 6165-6173.
[98]	Lin ZQ, von Gise A, Zhou PZ, Gu F, Ma Q, Jiang JM, Yau AL, Buck JN, Gouin KA, van Gorp PRR, Zhou B, Chen JH, Seidman JG, Wang DZ, Pu WT. Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model. Circ Res, 2014, 115(3): 354-363.
[99]	Chen LM, Chan SW, Zhang XQ, Walsh M, Lim CJ, Hong WJ, Song HW. Structural basis of YAP recognition by TEAD4 in the hippo pathway. Genes Dev, 2010, 24(3): 290-300.
[100]	Chen LM, Loh PG, Song HW. Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway. Protein Cell, 2010, 1(12): 1073-1083.
[101]	Tian W, Yu JZ, Tomchick DR, Pan DJ, Luo XL. Structural and functional analysis of the YAP-binding domain of human TEAD2. Proc Natl Acad Sci USA, 2010, 107(16): 7293-7298.
[102]	Li Z, Zhao B, Wang P, Chen F, Dong ZH, Yang HR, Guan KL, Xu YH. Structural insights into the YAP and TEAD complex. Genes & Development, 2010, 24(3): 235-240.
[103]	Kitagawa M. A Sveinsson's chorioretinal atrophy-associated missense mutation in mouse Tead1 affects its interaction with the co-factors YAP and TAZ. Biochem Biophys Res Commun, 2007, 361(4): 1022-1026.
[104]	Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA, Liu JO, Pan DJ. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev, 2012, 26(12): 1300-1305.
[105]	Guo T, Lu Y, Li PX, Yin MX, Lv DK, Zhang WJ, Wang HZ, Zhou ZC, Ji HB, Zhao Y, Zhang L. A novel partner of Scalloped regulates Hippo signaling via antagonizing Scalloped-Yorkie activity. Cell Res, 2013, 23(10): 1201-1214.
[106]	Zhang WJ, Gao YJ, Li PX, Shi ZB, Guo T, Li F, Han XK, Feng Y, Zheng C, Wang ZY, Li FM, Chen HQ, Zhou ZC, Zhang L, Ji HB. VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex. Cell Res, 2014, 24(3): 331-343.
[107]	Koontz LM, Liu-Chittenden Y, Yin F, Zheng YG, Yu JZ, Huang B, Chen Q, Wu SA, Pan DJ. The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression. Dev Cell, 2013, 25(4): 388-401.
[108]	Jiao S, Wang HZ, Shi ZB, Dong AM, Zhang WJ, Song XM, He F, Wang YC, Zhang ZZ, Wang WJ, Wang X, Guo T, Li PX, Zhao Y, Ji HB, Zhang L, Zhou ZC. A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell, 2014, 25(2): 166-180.
[109]	Zhao B, Kim J, Ye X, Lai ZC, Guan KL. Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein. Cancer Res, 2009, 69(3): 1089-1098.
[110]	Hao YW, Chun A, Cheung K, Rashidi B, Yang XL. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem, 2008, 283(9): 5496-5509.
[111]	Nolo R, Morrison CM, Tao CY, Zhang XW, Halder G. The bantam microRNA is a target of the hippo tumor-suppressor pathway. Curr Biol, 2006, 16(19): 1895-1904.
[112]	Shen SY, Guo XC, Yan H, Lu Y, Ji XY, Li L, Liang TB, Zhou DW, Feng XH, Zhao JC, Yu JD, Gong XG, Zhang L, Zhao B. A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis. Cell Res, 2015, 25(9): 997-1012.
[113]	Chen Q, Zhang NL, Xie R, Wang W, Cai J, Choi KS, David KK, Huang B, Yabuta N, Nojima H, Anders RA, Pan DJ. Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP. Genes Dev, 2015, 29(12): 1285-1297.
[114]	Moroishi T, Park HW, Qin BD, Chen Q, Meng ZP, Plouffe SW, Taniguchi K, Yu FX, Karin M, Pan DJ, Guan KL. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev, 2015, 29(12): 1271-1284.
[115]	Dai XM, Liu H, Shen SY, Guo XC, Yan H, Ji XY, Li L, Huang J, Feng XH, Zhao B. YAP activates the Hippo pathway in a negative feedback loop. Cell Res, 2015, 25(10): 1175-1178.
[116]	Strano S, Monti O, Pediconi N, Baccarini A, Fontemaggi G, Lapi E, Mantovani F, Damalas A, Citro G, Sacchi A, Del SG, Levrero M, Blandino G. The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage. Mol Cell, 2005, 18(4): 447-459.
[117]	Murakami M, Tominaga J, Makita R, Uchijima Y, Kurihara Y, Nakagawa O, Asano T, Kurihara H. Transcriptional activity of Pax3 is co-activated by TAZ. Biochem Biophys Res Commun, 2006, 339(2): 533-539.
[118]	Park KS, Whitsett JA, Di Palma T, Hong JH, Yaffe MB, Zannini M. TAZ interacts with TTF-1 and regulates expression of surfactant protein-C. J Biol Chem, 2004, 279(17): 17384-17390.
[119]	Murakami M, Nakagawa M, Olson EN, Nakagawa O. A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc Natl Acad Sci USA, 2005, 102(50): 18034-18039.
[120]	Cui CB, Cooper LF, Yang XL, Karsenty G, Aukhil I. Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Mol Cell Biol, 2003, 23(3): 1004-1013.
[121]	Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R, Mueller E, Benjamin T, Spiegelman BM, Sharp PA, Hopkins N, Yaffe MB. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science, 2005, 309(5737): 1074-1078.
[122]	Alarcóon C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S, Barlas A, Miller AN, Manova-Todorova K, Macias MJ, Sapkota G, Pan D, Massagué J. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell, 2009, 139(4): 757-769.
[123]	Yao MH, Wang YD, Zhang P, Chen H, Xu ZH, Jiao JW, Yuan ZQ. BMP2-SMAD signaling represses the proliferation of embryonic neural stem cells through YAP. J Neurosci, 2014, 34(36): 12039-12048.
[124]	Lapi E, Di Agostino S, Donzelli S, Gal H, Domany E, Rechavi G, Pandolfi PP, Givol D, Strano S, Lu X, Blandino G. PML, YAP, p73 are components of a proapoptotic autoregulatory feedback loop. Mol Cell, 2008, 32(6): 803-814.
[125]	Chan SW, Lim CJ, Huang C, Chong YF, Gunaratne HJ, Hogue KA, Blackstock WP, Harvey KF, Hong W. WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ. Oncogene, 2011, 30(5): 600-610.
[126]	Zhang X, Milton CC, Poon CLC, Hong W, Harvey KF. Wbp2 cooperates with Yorkie to drive tissue growth downstream of the Salvador-Warts-Hippo pathway. Cell Death Differ, 2011, 18(8): 1346-1355.
[127]	Zhi X, Zhao D, Zhou ZM, Liu R, Chen CS. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor. Am J Pathol, 2012, 180(6): 2452-2461.
[128]	Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, Johnson RL, Martin JF. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science, 2011, 332(6028): 458-461.
[129]	Stein C, Bardet AF, Roma G, Bergling S, Clay I, Ruchti A, Agarinis C, Schmelzle T, Bouwmeester T, Schubeler D, Bauer A. YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers. PLoS Genet, 2015, 11(8): e1005465.
[130]	Galli GG, Carrara M, Yuan WC, Valdes-Quezada C, Gurung B, Pepe-Mooney B, Zhang TH, Geeven G, Gray NS, de Laat W, Calogero RA, Camargo FD. YAP drives growth by controlling transcriptional pause release from dynamic enhancers. Mol Cell, 2015, 60(2): 328-337.
[131]	Zanconato F, Forcato M, Battilana G, Azzolin L, Quaranta E, Bodega B, Rosato A, Bicciato S, Cordenonsi M, Piccolo S. Genome-wide association between YAP/ TAZ/TEAD and AP-1 at enhancers drives oncogenic growth. Nat Cell Biol, 2015, 17(9): 1218-1227.
[132]	Halder G, Johnson RL. Hippo signaling: growth control and beyond. Development, 2011, 138(1): 9-22.
[133]	Pan DJ. The hippo signaling pathway in development and cancer. Dev Cell, 2010, 19(4): 491-505.
[134]	Yu FX, Zhao B, Guan KL. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell, 2015, 163(4): 811-828.
[135]	Zhang NL, Bai HB, David KK, Dong JX, Zheng YG, Cai J, Giovannini M, Liu PT, Anders RA, Pan DJ. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell, 2010, 19(1): 27-38.
[136]	Cai J, Zhang NL, Zheng YG, de Wilde RF, Maitra A, Pan DJ. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev, 2010, 24(21): 2383-2388.
[137]	Chen Q, Zhang NL, Gray RS, Li HL, Ewald AJ, Zahnow CA, Pan DJ. A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis. Genes Dev, 2014, 28(5): 432-437.
[138]	Bai HB, Zhang NL, Xu Y, Chen Q, Khan M, Potter JJ, Nayar SK, Cornish T, Alpini G, Bronk S, Pan DJ, Anders RA. Yes-associated protein regulates the hepatic response after bile duct ligation. Hepatology, 2012, 56(3): 1097-1107.
[139]	Su T, Bondar T, Zhou X, Zhang C, He H, Medzhitov R. Two-signal requirement for growth-promoting function of Yap in hepatocytes. Elife, 2015, 4, doi: 10.7554/ eLife.02948.
[140]	Yimlamai D, Christodoulou C, Galli GG, Yanger K, Pepe-Mooney B, Gurung B, Shrestha K, Cahan P, Stanger BZ, Camargo FD. Hippo pathway activity influences liver cell fate. Cell, 2014, 157(6): 1324-1338.
[141]	Zhou D, Zhang Y, Wu H, Barry E, Yin Y, Lawrence E, Dawson D, Willis JE, Markowitz SD, Camargo FD, Avruch J. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci USA, 2011, 108(49): E1312-E1320.
[142]	Zhang H, Pasolli HA, Fuchs E. Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin. Proc Natl Acad Sci USA, 2011, 108(6): 2270-2275.
[143]	Grijalva JL, Huizenga M, Mueller K, Rodriguez S, Brazzo J, Camargo F, Sadri-Vakili G, Vakili K. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Am J Physiol Gastrointest Liver Physiol, 2014, 307(2): G196-G204.
[158]	Guo XC, Zhao Y, Yan H, Yang YC, Shen SY, Dai XM, Ji XY, Ji FB, Gong XG, Li L, Bai XL, Feng XH, Liang TB, Ji JF, Chen L, Wang HY, Zhao B. Single tumor-initiating cells evade immune clearance by recruiting type II macrophages. Genes Dev, 2017, 31(3): 247-259.
[159]	Li WY, Xiao J, Zhou X, Xu M, Hu CB, Xu XY, Lu Y, Liu C, Xue SJ, Nie L, Zhang HB, Li ZQ, Zhang YB, Ji F, Hui LJ, Tao WF, Wei B, Wang HY. STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma. J Clin Invest, 2015, 125(11): 4239-4254.
[160]	Liu B, Zheng YG, Yin F, Yu JZ, Silverman N, Pan DJ. Toll receptor-mediated hippo signaling controls innate immunity in drosophila. Cell, 2016, 164(3): 406-419.
[161]	Geng J, Sun XF, Wang P, Zhang SH, Wang XZ, Wu HT, Hong LX, Xie CC, Li X, Zhao H, Liu QX, Jiang MT, Chen QH, Zhang JJ, Li Y, Song SY, Wang HR, Zhou RB, Johnson RL, Chien KY, Lin SC, Han JH, Avruch J, Chen LF, Zhou DW. Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity. Nat Immunol, 2015, 16(11): 1142-1152.
[162]	Zhang Q, Meng FS, Chen SS, Plouffe SW, Wu SY, Liu SD, Li XR, Zhou RY, Wang JX, Zhao B, Liu JM, Qin J, Zou J, Feng XH, Guan KL, Xu PL. Hippo signalling governs cytosolic nucleic acid sensing through YAP/TAZ-mediated TBK1 blockade. Nat Cell Biol, 2017, 19(4): 362-374.
[163]	Azzolin L, Panciera T, Soligo S, Enzo E, Bicciato S, Dupont S, Bresolin S, Frasson C, Basso G, Guzzardo V, Fassina A, Cordenonsi M, Piccolo S. YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response. Cell, 2014, 158(1): 157-170.
[164]	Barry ER, Morikawa T, Butler BL, Shrestha K, de la Rosa R, Yan KS, Fuchs CS, Magness ST, Smits R, Ogino S, Kuo CJ, Camargo FD. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature, 2013, 493(7430): 106-110.
[165]	Imajo M, Miyatake K, Iimura A, Miyamoto A, Nishida E. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling. EMBO J, 2012, 31(5): 1109-1122.
[166]	Cottini F, Hideshima T, Xu CX, Sattler M, Dori M, Agnelli L, Ten Hacken E, Bertilaccio MT, Antonini E, Neri A, Ponzoni M, Marcatti M, Richardson PG, Carrasco R, Kimmelman AC, Wong KK, Caligaris-Cappio F, Blandino G, Kuehl WM, Anderson KC, Tonon G. Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers. Nat Med, 2014, 20(6): 599-606.

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

哺乳动物Hippo信号通路分子机制研究进展

Molecular mechanisms of the mammalian Hippo signaling pathway

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	程香荣,胡兴琳,姜琦,黄星卫,王楠,雷蕾. 核糖体DNA转录的表观调控与肿瘤发生[J]. 遗传, 2019, 41(3): 185-192.
[2]	李鑫,李梦玮,张依楠,徐寒梅. 常用肿瘤基因分析方法及基于TCGA数据库的分析应用[J]. 遗传, 2019, 41(3): 234-242.
[3]	吴保军,王卓,董宇,邓宇亮,施奇惠. 肺癌恶性胸腔积液中稀有肿瘤细胞的鉴定与单细胞测序分析[J]. 遗传, 2019, 41(2): 175-184.
[4]	张豪, 张志鹏, 郭晓东, 马敏, 敖月, 刘旭, 马小燕, 梁浩, 郭旭东. cgVEGF164基因对小鼠毛囊生长的影响[J]. 遗传, 2019, 41(1): 76-84.
[5]	黎伟, 秦俊, 汪晖, 陈廖斌. 表观遗传生物标志物在人类疾病早期诊治中的研究进展[J]. 遗传, 2018, 40(2): 104-115.
[6]	王天工, 叶孟. m ⁶A甲基化与肿瘤研究进展[J]. 遗传, 2018, 40(12): 1055-1065.
[7]	孙书国, 吴世安, 张雷. Hippo信号通路在果蝇遗传学研究中的发现与扩展[J]. 遗传, 2017, 39(7): 537-545.
[8]	张平平,佟鑫,张天乐,黎子琛,龚清秋. 植物Hippo信号通路研究进展[J]. 遗传, 2017, 39(7): 568-575.
[9]	王永煜,余薇,周斌. Hippo信号通路与心血管发育及疾病调控[J]. 遗传, 2017, 39(7): 576-587.
[10]	顾远, 张雷, 余发星. Hippo信号通路在肠道稳态、再生及癌变过程中的作用及机制[J]. 遗传, 2017, 39(7): 588-596.
[11]	付思玲,赵婉滢,张雯婧,宋海,季红斌,汤楠. Hippo信号通路在肺发育、再生和疾病中的功能[J]. 遗传, 2017, 39(7): 597-606.
[12]	李玉席, 李俊宏, 周大旺. Hippo信号通路与肝脏稳态调控及疾病发生[J]. 遗传, 2017, 39(7): 607-616.
[13]	姚传波, 周鑫, 陈策实, 雷群英. Hippo信号通路在乳腺癌中的调控机制及作用[J]. 遗传, 2017, 39(7): 617-629.
[14]	包笑妹, 何晴, 王莹, 黄智慧, 袁增强. Hippo/YAP信号通路在神经系统中的作用及机制研究进展[J]. 遗传, 2017, 39(7): 630-641.
[15]	周欣,李伟芸,王红艳. MST1/2调控先天免疫的功能和机制[J]. 遗传, 2017, 39(7): 642-649.